Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/28/2000 | EP1013771A1 Non-nuclear chromosomal transformation |
06/28/2000 | EP1013766A2 Peptides for the detection of HIV-1-Group O |
06/28/2000 | EP1013765A1 Gene and method for producing L-amino acids |
06/28/2000 | EP1013764A1 Immunomodulators |
06/28/2000 | EP1013763A1 CANINE INTERLEUKIN 18, CANINE INTERLEUKIN 1$g(b) CONVERTASE, DNA SEQUENCES ENCODING THE SAME, PROCESS FOR PRODUCING INTERLE UKIN 18, AND REMEDIES FOR CANINE IMMUNOLOGICAL DISEASES |
06/28/2000 | EP1013762A2 Delta-like gene expressed in neuroendocrine tumors |
06/28/2000 | EP1013761A2 Humanized chimeric antibody directed against ganglioside GD3 |
06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
06/28/2000 | EP1013757A2 Attenuated forms of bovine viral diarrhea virus |
06/28/2000 | EP1013667A2 Process for preparation of cytokine using a sendai virus expression system |
06/28/2000 | EP1013666A2 Methods for obtaining a p53/p90 complex |
06/28/2000 | EP1013665A1 Novel polypeptide having water channel activity and dna sequence |
06/28/2000 | EP1013664A1 Antigenic determinants for drug-specific T lymphocytes from drug-allergic patients |
06/28/2000 | EP1013288A2 Erythropoietin in the treatment of domestic and livestock animals for anemia |
06/28/2000 | EP1013285A2 Urokinase-type plasminogen activator receptor |
06/28/2000 | EP1013284A2 Purified forms of dnase |
06/28/2000 | EP1012741A1 Small molecule mimetics of erythropoietin |
06/28/2000 | EP1012603A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
06/28/2000 | EP1012343A1 Reagents and methods useful for detecting diseases of the prostate |
06/28/2000 | EP1012341A1 An alpha-2 macroglobulin diagnostic test |
06/28/2000 | EP1012338A1 A tumor suppressor designated ts10q23.3 |
06/28/2000 | EP1012333A1 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23 |
06/28/2000 | EP1012329A1 Diagnosis and treatment of myocardial failure |
06/28/2000 | EP1012328A2 Dna-sequence-based diagnosis of mastitis from a milk sample |
06/28/2000 | EP1012324A1 Promiscuous g-protein compositions and their use |
06/28/2000 | EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
06/28/2000 | EP1012319A2 Insect expression vectors |
06/28/2000 | EP1012316A1 Rank1, an ankyrin-repeat containing peptide from rice associated with disease resistance |
06/28/2000 | EP1012315A1 Recombinant vectors |
06/28/2000 | EP1012313A1 INTRACELLULAR INHIBITORS OF Gq PROTEIN SIGNALING |
06/28/2000 | EP1012312A1 Mosaic protein and restriction endonuclease assisted ligation method for making the same |
06/28/2000 | EP1012311A1 G protein chimeras |
06/28/2000 | EP1012310A1 Fusion proteins comprising coiled-coil structures |
06/28/2000 | EP1012309A2 Chimeric polypeptides containing chemokine domains |
06/28/2000 | EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
06/28/2000 | EP1012303A1 Factor x deletion mutants and analogues thereof |
06/28/2000 | EP1012298A1 Yeast strains for the production of lactic acid |
06/28/2000 | EP1012296A2 Mammalian thioredoxin |
06/28/2000 | EP1012295A1 Alphavirus rna replicon systems |
06/28/2000 | EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
06/28/2000 | EP1012292A1 Ntn-2 member of tnf ligand family |
06/28/2000 | EP1012291A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis |
06/28/2000 | EP1012290A1 EXPRESSION OF GONADOTROPINS IN $i(DICTYOSTELIUM) |
06/28/2000 | EP1012288A1 Novel human cystatin-like protein |
06/28/2000 | EP1012287A1 Synthetic polypeptide for diagnosing and treating prion-related diseases |
06/28/2000 | EP1012286A2 Allelic variant of human stat3 |
06/28/2000 | EP1012285A1 Beta-defensins |
06/28/2000 | EP1012284A1 Mpl ligand analogs |
06/28/2000 | EP1012283A1 Mage-3 peptides presented by hla class ii molecules |
06/28/2000 | EP1012282A1 Cysteine rich receptors-train |
06/28/2000 | EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide |
06/28/2000 | EP1012280A1 Trimerising module |
06/28/2000 | EP1012279A1 Mitofusin genes and their uses |
06/28/2000 | EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them |
06/28/2000 | EP1012277A2 Syndecan interacting proteins and the use thereof |
06/28/2000 | EP1012276A2 Recombinant pox virus for immunization against muc1 tumor-associated antigen |
06/28/2000 | EP1012275A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response |
06/28/2000 | EP1012274A1 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l) |
06/28/2000 | EP1012273A2 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012272A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124 |
06/28/2000 | EP1012271A1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
06/28/2000 | EP1012270A2 Kay - a novel immune system protein |
06/28/2000 | EP1012269A2 P13 antigens from borrelia |
06/28/2000 | EP1012268A1 Ires sequences with high translational efficiency and expression vectors containing the sequence |
06/28/2000 | EP1012266A1 Galectin 8, 9, 10 and 10sv |
06/28/2000 | EP1012265A1 Repressed trans-activator system for characterization of protein-protein interactions |
06/28/2000 | EP1012263A1 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012262A1 Human frezzled-like protein |
06/28/2000 | EP1012261A1 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012260A1 Interleukin-20 |
06/28/2000 | EP1012259A2 Tumor targeted vector |
06/28/2000 | EP1012258A1 Dna encoding canine interleukin-1 receptor antagonist |
06/28/2000 | EP1012257A1 Methods and materials for making and using transgenic dicamba-degrading organisms |
06/28/2000 | EP1012256A2 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album |
06/28/2000 | EP1012255A1 Enhancement of growth in plants |
06/28/2000 | EP1012249A1 Plus end-directed microtubule motor required for chromosome congression |
06/28/2000 | EP1012245A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein |
06/28/2000 | EP1012244A1 Rhabdoviruses with reengineered coats |
06/28/2000 | EP1012243A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
06/28/2000 | EP1012242A1 Human sigma receptor |
06/28/2000 | EP1012236A1 Retrovirus and viral vectors |
06/28/2000 | EP1012233A1 Transgenically produced prolactin |
06/28/2000 | EP1012232A1 Genetically modified tumor-targeted bacteria with reduced virulence |
06/28/2000 | EP1012231A1 Dna molecules encoding ctenocephalides felis glutamate gated chloride channels |
06/28/2000 | EP1012230A1 Renibacterium salmoninarum vaccine |
06/28/2000 | EP1012229A1 Regulators of ucp2 gene expression |
06/28/2000 | EP1012191A1 Method for obtaining high-purity vwf or factor viii/vwf complex |
06/28/2000 | EP1012190A1 Eosinophil eotaxin receptor |
06/28/2000 | EP1012189A1 Treatment of obesity |
06/28/2000 | EP1012188A1 Composition for treating diabetes mellitus and obesity |
06/28/2000 | EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
06/28/2000 | EP1012186A2 Keratinocyte growth factors and uses thereof |
06/28/2000 | EP1012185A1 Retro-inverso neurotrophic and analgesic peptides |
06/28/2000 | EP1012184A1 Derivatives of growth hormone and related proteins |
06/28/2000 | EP1012183A1 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein |
06/28/2000 | EP1012182A2 Chlamydia pneumoniae specific peptides and their use in diagnostic assays |
06/28/2000 | EP1012181A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
06/28/2000 | EP1012180A2 Hepatitis c inhibitor peptide analogues |
06/28/2000 | EP1012179A2 Cysteine rich receptors: trail |
06/28/2000 | EP1012178A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |